| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 376 | 2017 |
| Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages D Stucki, D Brites, L Jeljeli, M Coscolla, Q Liu, A Trauner, L Fenner, ... Nature genetics 48 (12), 1535-1543, 2016 | 365 | 2016 |
| Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label … R Dawson, AH Diacon, D Everitt, C van Niekerk, PR Donald, DA Burger, ... The Lancet 385 (9979), 1738-1747, 2015 | 292 | 2015 |
| Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study D Portevin, F Moukambi, P Clowes, A Bauer, M Chachage, NE Ntinginya, ... The Lancet infectious diseases 14 (10), 931-938, 2014 | 161 | 2014 |
| Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a … CD Tweed, R Dawson, DA Burger, A Conradie, AM Crook, CM Mendel, ... The Lancet Respiratory Medicine 7 (12), 1048-1058, 2019 | 133 | 2019 |
| Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study I Sabi, A Rachow, D Mapamba, P Clowes, NE Ntinginya, M Sasamalo, ... Journal of Infection 77 (4), 321-327, 2018 | 83 | 2018 |
| The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially … R Bowness, MJ Boeree, R Aarnoutse, R Dawson, A Diacon, C Mangu, ... Journal of Antimicrobial Chemotherapy 70 (2), 448-455, 2015 | 69 | 2015 |
| Extreme Drug Tolerance of Mycobacterium abscessus “Persisters” YK Yam, N Alvarez, ML Go, T Dick Frontiers in microbiology 11, 359, 2020 | 67* | 2020 |
| TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB–a study protocol A Rachow, O Ivanova, R Wallis, S Charalambous, I Jani, N Bhatt, ... BMC pulmonary medicine 19, 1-9, 2019 | 62 | 2019 |
| Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy MIM Ahmed, NE Ntinginya, G Kibiki, BA Mtafya, H Semvua, S Mpagama, ... Frontiers in immunology 9, 2247, 2018 | 56 | 2018 |
| Dispensing antibiotics without prescription at community pharmacies and accredited drug dispensing outlets in Tanzania: a cross-sectional study PM Ndaki, MF Mushi, JR Mwanga, ET Konje, NE Ntinginya, BT Mmbaga, ... Antibiotics 10 (8), 1025, 2021 | 53 | 2021 |
| Tanzania's position on the COVID-19 pandemic SG Mfinanga, NP Mnyambwa, DT Minja, NE Ntinginya, E Ngadaya, ... The Lancet 397 (10284), 1542-1543, 2021 | 51 | 2021 |
| Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study KM Manz, P Clowes, I Kroidl, DO Kowuor, C Geldmacher, NE Ntinginya, ... PLoS One 12 (4), e0175137, 2017 | 50 | 2017 |
| Seroprevalence of Alphavirus Antibodies in a Cross-Sectional Study in Southwestern Tanzania Suggests Endemic Circulation of Chikungunya N Weller, P Clowes, G Dobler, E Saathoff, I Kroidl, NE Ntinginya, ... PLoS Neglected Tropical Diseases 8 (7), e2979, 2014 | 40 | 2014 |
| Molecular bacterial load assay concurs with culture on NaOH-induced loss of Mycobacterium tuberculosis viability B Mtafya, W Sabiiti, I Sabi, J John, E Sichone, NE Ntinginya, SH Gillespie Journal of clinical microbiology 57 (7), 10.1128/jcm. 01992-18, 2019 | 35 | 2019 |
| Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study E Nkereuwem, T Togun, MP Gomez, R Székely, A Macé, D Jobe, ... The Lancet Infectious Diseases 21 (3), 376-384, 2021 | 33 | 2021 |
| Protocol for an interdisciplinary cross-sectional study investigating the social, biological and community-level drivers of antimicrobial resistance (AMR): Holistic Approach to … BB Asiimwe, J Kiiru, SE Mshana, S Neema, K Keenan, M Kesby, ... BMJ open 11 (3), e041418, 2021 | 26 | 2021 |
| The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda DL Green, K Keenan, KJ Fredricks, SI Huque, MF Mushi, C Kansiime, ... The Lancet Global Health 11 (1), e59-e68, 2023 | 25 | 2023 |
| Wuchereria bancrofti infection is linked to systemic activation of CD4 and CD8 T cells I Kroidl, M Chachage, J Mnkai, A Nsojo, M Berninghoff, JJ Verweij, ... PLoS neglected tropical diseases 13 (8), e0007623, 2019 | 24 | 2019 |
| Rabies mortality and morbidity associated with animal bites in Africa: a case for integrated rabies disease surveillance, prevention and control: a scoping review PS Nyasulu, J Weyer, R Tschopp, A Mihret, A Aseffa, SV Nuvor, ... BMJ open 11 (12), e048551, 2021 | 23 | 2021 |
Michael HoelscherDirektor Tropenmedizin, Klinikum der LMUVerified email at lrz.uni-muenchen.de
